Clinigen Group Receives Hold Rating from Investec (CLIN)
Clinigen Group (LON:CLIN)‘s stock had its “hold” rating reiterated by investment analysts at Investec in a note issued to investors on Wednesday, AR Network reports.
Clinigen Group (LON:CLIN) opened at 439.00 on Wednesday. Clinigen Group has a 52-week low of GBX 195.00 and a 52-week high of GBX 405.00. The stock has a 50-day moving average of GBX 376.8 and a 200-day moving average of GBX 302.7.
CLIN has been the subject of a number of other recent research reports. Analysts at Numis Securities Ltd reiterated a “buy” rating on shares of Clinigen Group (LON:CLIN) in a research note to investors on Wednesday. They now have a GBX 485 ($7.77) price target on the stock.
Clinigen Group plc (LON:CLIN) is a specialty pharmaceuticals and services business company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.